Identifying successful biomarkers for patients with non-small-cell lung cancer

Ítems similars

• The crucial role of predicting brain metastases development in non-small cell lung cancer patients
  per: Addeo, Alfredo, et al.
  Publicat: (2018)
• Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
  per: Banna, Giuseppe Luigi, et al.
  Publicat: (2020)
• How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere
  per: Banna, Giuseppe, et al.
  Publicat: (2020)
• Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
  per: Chevallier, Mathieu, et al.
  Publicat: (2021)
• Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic
  per: Friedlaender, Alex, et al.
  Publicat: (2020)